4.7 Article

De novo mutations in folate-related genes associated with common disorders

Journal

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL
Volume 19, Issue -, Pages 1414-1422

Publisher

ELSEVIER
DOI: 10.1016/j.csbj.2021.02.011

Keywords

Developmental disorders; Folate-related gene; Candidate disease-associated genes; Expression patterns; De novo mutation

Funding

  1. National Natural Science Foundation of China [81801133, 81730036]
  2. Young Elite Scientist Sponsorship Program of the China Association for Science and Technology [2018QNRC001]
  3. Central South University's Innovation-Driven Project [20180033040004]
  4. Science and Technology Major Projectof Hunan Provincial Science and Technology Department [2018SK1030]
  5. Hunan Natural Science Foundation Outstanding Youth Fund [2020JJ3059]

Ask authors/readers for more resources

The study identified an association between de novo mutations in folate-related genes and the risk of developmental disorders. By analyzing genetic data, 96 candidate disease-associated genes were prioritized, playing crucial roles in development. The findings contribute to the discovery of biomarkers and therapeutic targets for developmental disorders.
Folate deficiency is an environmental risk factor for several developmental disorders. De novo mutations (DNMs) also play important etiological roles in various developmental disorders. However, it remains unclear whether DNMs in folate-related genes (FRGs) contribute to developmental disorders. We obtained a list of 1,821 FRGs from folate metabolism pathways and the Comparative Toxicogenomics Database, along with data concerning DNMs in 15,404 cases and 3,391 controls from the Gene4Denovo database. We used a TADA-Denovo model to prioritize candidate disease-associated FRGs, and characterized these genes in terms of genic intolerance, functional networks, and expression patterns. Compared with the controls, FRGs were significantly enriched in likely damaging DNMs (ldDNMs) in patients with developmental disorders (1.54 <= odds ratio <= 3.39, P-adj <= 0.0075). Furthermore, FRGs with ldDNMs rather than with likely non-damaging DNMs (lndDNMs) overlapped significantly among the five developmental disorders included in the datasets. The TADA-Denovo model prioritized 96 candidate disease-associated FRGs, which were intolerant to genetic variants. Their functional networks mainly involved pathways associated with chromatin modification, organ development, and signal transduction pathways. DNMT3A, KMT2B, KMT2C, and YY1 emerged as hub FRGs from the protein-protein interaction network. These candidate disease-associated FRGs are preferentially expressed in the excitatory neurones during embryonic development, and in the cortex, cerebellum, striatum, and amygdala during foetal development. Overall, these findings show that DNMs in FRGs are associated with the risk of developmental disorders. Further research on these DNMs may facilitate the discovery of developmental disorder biomarkers and therapeutic targets, enabling detailed, personalized, and precise folate treatment plan. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available